The Safety of Systemic Treatments That Can Be Used for Geriatric Psoriasis Patients: A Review
Background. Patients with moderate-to-severe psoriasis are often treated with systemic immunosuppressant agents that decrease immune system function. For the elderly, these medications are often problematic due to their already immunosuppressed state and comorbidities. However, there are few studies...
Saved in:
Main Authors: | Jillian W. Wong, John Y. M. Koo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Dermatology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2012/367475 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Geriatric Psoriasis: Evaluation of Clinical Features, Disease Course, and Treatment Modalities of Patients from a Tertiary Care Hospital
by: Elif Çalışkan, et al.
Published: (2025-01-01) -
Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01) -
Meta-analysis of the efficacy and safety of secukinumab in the treatment of moderate to severe psoriasis
by: Yanxia Cai, et al.
Published: (2025-01-01) -
Characterization of the geriatric patient with thyroid nodules
by: Jessica González Manreza, et al.
Published: (2023-07-01) -
Delirium in geriatric patients with hip fracture
by: A. Konkayev, et al.
Published: (2021-03-01)